CDP COPT Defense Properties
$33.93▼ -0.50%
RealEstate
Other
After hours
$33.93▲ +0.00%
Oct 27, 4:00 PM ET
Volume 549.6K
Avg Volume (10D) 708.5K
Key Metrics & Fundamentals
Market Cap
$3.93B
P/E Ratio
23.6
Div Yield
3.75%
52W Range
27.06 - 38.90
% vs 50 MA
-2.15%
% vs 200 MA
1.18%
RSI-14
50.9
MACD Histogram
+0.1700
Beta (1Y vs SPY)
0.12
Free Cash Flow
$89.00M
Gross Rev
$197.39M
Gross Profit
$76.49M
EBITDA
$109.35M
COGS
$120.90M
Operating Exp
$13.26M
Operating Income
$63.23M
EBIT
$63.23M
Pretax Income
$48.59M
Net Income
$46.44M
EPS (Diluted)
0.40
Price & Volume History
Loading chart…
Recent News

Easterly Government Properties (DEA) Misses Q3 FFO and Revenue Estimates
Zacks · Oct 26, 2026 6:40 AM ET

COPT Defense (CDP) Could Be a Great Choice
Zacks · Oct 14, 2026 10:45 AM ET

COPT Defense Properties (CDP) Pulls Back, Is It Still A Bargain?
Simply Wall St. · Oct 8, 2026 1:17 AM ET

COPT Defense Provides Conference Call Details to Discuss 3Q 2026 Results
Business Wire · Oct 1, 2026 4:16 PM ET

Are You Looking for a High-Growth Dividend Stock?
Zacks · Sep 28, 2026 10:45 AM ET

COPT Defense (CDP) Keeps Leasing Ahead Of Its Own Targets
Insider Monkey · Sep 17, 2026 3:31 AM ET

COPT Defense (CDP) Could Be a Great Choice
Zacks · Sep 11, 2026 11:45 AM ET
COPT Defense's Year-to-Date Vacancy Leasing Reaches 408,000 Square Feet
MT Newswires · Sep 9, 2026 5:37 PM ET

COPT Defense Provides an Update on Leasing Activity and Capital Commitments to New Investments
Business Wire · Sep 9, 2026 4:16 PM ET

Are You Looking for a High-Growth Dividend Stock?
Zacks · Aug 26, 2026 11:45 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CDP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.